Fiocruz

Brazil
Public health research, education, and services are provided in Brazil.

About Fiocruz

Fiocruz is a Government & Social Sector company based in Brazil. Public health research, education, and services are provided in Brazil. Its website fiocruz.br draws about 1.7 million monthly visits. Fiocruz offers products and services including Health Research and Vaccine Development. Its focus areas include Nonprofits and Foundations. Its legal entity is Fundação Oswaldo Cruz.

Company details

Public health research, education, and services are delivered by Fiocruz in Brazil. Operations focus on infectious diseases, environmental health, and health inequalities within the biomedicine sector. Educational programs range from undergraduate to postgraduate levels, while direct services involve vaccine development, diagnostic tools, and policy implementation. Collaborations with government and non-governmental entities support health outcome improvements, backed by biological collections and technological platforms.

  • Headquarters Brazil
  • Sectors
    Government & Social Sector
  • Website category Science and Education · Universities and Colleges
  • Website fiocruz.br
  • Social X Facebook Instagram
  • Legal Name Fundação Oswaldo Cruz
Key Metrics
  • Latest Funding Round
    $59.62K (USD), Grant

    Dec 2023

  • Investors
    HHS

    & 1 more

Products & Services of Fiocruz

Fiocruz offers a comprehensive portfolio of products and services, including Health Research and Vaccine Development.

Health Research
Scientific Services

Health research is conducted by Fiocruz in areas like infectious diseases and public health to advance knowledge and solutions.

Vaccine Development
Medical Products

Vaccine development is undertaken by Fiocruz for various diseases, ensuring production and distribution for public health needs.

Funding Insights of Fiocruz

  • Total Rounds 4
  • Last Round Grant — $59,621
  • First Round $10.76M

    (Dec 2008)

  • Investors Count 2

All 4 funding rounds of Fiocruz with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2023$59,621Grant––
Aug 2022$609,825Grant––
Jan 2019Grant––
Dec 2008$10.76MGrant––
Valuation history

2 investors in total: 2 institutional.

Investors in Fiocruz

Fiocruz has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Public health and human services are overseen by HHS.
1953hhs.gov
Premium access

Investor details for Fiocruz

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Fiocruz

2 dated milestones of Fiocruz across 15 years, from founding to its latest funding, stage changes and deals.

  1. Funding First funding round of $10.8M.
  2. Funding Latest funding round, Grant, of $60K.

Web traffic of Fiocruz

The website of Fiocruz (fiocruz.br) receives about 1.7M visits a month and ranks #22,215 among all websites worldwide, #1,233 in Universities and Colleges.

  • Monthly visits
    1.7M

    ▲ 5.7% vs previous month

  • Unique visitors
    651.6K

    per month

  • Global rank
    #22,215

    among all websites

  • Category rank
    #1,233

    Science and Education · Universities and Colleges

Similar websites

Websites whose visitors overlap most with Fiocruz. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
even3.com.br
100%
1.8M#26,272View details
ufrgs.br
98%
3.1M#11,774View details
unirio.br
unirio.br
95%
#86,257–
ufmg.br
95%
8.7M#6,406View details
ufsm.br
95%
#52,487View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Fiocruz

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Fiocruz

Fiocruz is headquartered in Brazil.

Public health research, education, and services are delivered by Fiocruz in Brazil. Operations focus on infectious diseases, environmental health, and health inequalities within the biomedicine sector. Educational programs range from undergraduate to postgraduate levels, while direct services involve vaccine development, diagnostic tools, and policy implementation. Collaborations with government and non-governmental entities support health outcome improvements, backed by biological collections and technological platforms.

Fiocruz offers Health Research and Vaccine Development.

Fiocruz has 2 investors. Key investors include HHS, and European Union.

Fiocruz operates through Fundação Oswaldo Cruz.

The website of Fiocruz receives about 1.7 million visits a month and ranks #22,215 among all websites worldwide.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available